Skip to main content

Lawsuits Allege Gadolinium For Its Health Risks

Lawsuits Allege Gadolinium For Its Health Risks

Lawsuits Allege Gadolinium For Its Health Risks

Introduction

Magnevist (gadopentetate dimeglumine) is one of the eight gadolinium-based MRI contrast dye agents approved by the U.S. Food & Drug Administration (FDA), to enhance MRI scan results. It has been linked to reports of a painful and debilitating condition known as Gadolinium Deposition Disease.

According to a recent lawsuit filed in the U.S. District Court for the Northern District of California on May 13, a plaintiff alleged exposure to Magnevist during an MRI exam caused brain fog, joint pain, and skin problems which are the symptoms of Gadolinium Deposition Disease (GDD). Further allegations faced by defendants Bayer Corporation and McKesson Corporation include failure to warn, negligence, design defect, misrepresentation, breach of warranty, negligent misrepresentation, fraudulent misrepresentation, and consumer protection violations.

The lawsuits against MRI gadolinium are increasing in numbers in recent months, each raising similar allegations over its side effects. Gadolinium related lawsuits are centralized under MDL No. 1909; In Re: Gadolinium Contrast Dyes Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.